Harvard Bioscience Inc

HBIO

Company Profile

  • Business description

    Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

  • Contact

    84 October Hill Road
    HollistonMA01746
    USA

    T: +1 508 893-8999

    E: [email protected]

    https://www.harvardbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    339

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,592.90103.70-1.19%
CAC 407,726.2060.580.79%
DAX 4022,653.86273.671.22%
Dow JONES (US)46,208.47631.001.38%
FTSE 1009,894.1524.18-0.24%
HKSE24,731.42348.951.43%
NASDAQ21,946.76299.151.38%
Nikkei 22551,840.82325.330.63%
NZX 50 Index12,701.75197.97-1.53%
S&P 5006,581.0074.521.15%
S&P/ASX 2008,401.90102.70-1.21%
SSE Composite Index3,838.2124.930.65%

Market Movers